The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Allos Therapeutics, Inc.

Allos Therapeutics, Inc.
Nasdaq: ALTH
Change
symbol:
     
 PROFILE
What spinach is for Popeye, Allos Therapeutics' drug candidates are for chemotherapy. The development-stage firm is developing drugs that improve existing cancer treatments by increasing the amount of oxygen released from red blood cells. (Poorly oxygenated cancer cells resist radiation.) Lead candidate RSR13 has received fast track designation from FDA as a potential adjuvant to brain metastases treatments. Allos plans to market RSR13 directly to radiation therapists in the US. The firm is also researching other uses for RSR13, including improved treatments for cardiovascular diseases and strokes; it will seek licensing agreements with other pharmaceutical firms to market the product to these sectors.

 COMPETITION
GlaxoSmithKline plc (GSK)
NeoRx Corporation (NERX)
Vion Pharmaceuticals, Inc. (VION)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 0.10
1-Yr. Sales Growth: 0.0%
Employees: 50
Revenue per employee: $2,000.00

 KEY PEOPLE
• Stephen J. Hoffman
    CEO
• Michael E. Hart
    CFO

 CONTACT INFO
7000 N. Broadway, Ste. 400
Denver, CO 80221
US
Phone: 303-426-6262
Fax: 303-412-9160
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001